The global demand for Interventional Oncology Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Interventional oncology (abbreviated IO) is a subspecialty medical field of interventional radiology that deals with the treatment and diagnosis of different types of cancers and cancer-related problems using targeted minimally invasive procedures performed under image guidance. In interventional oncology procedures, various image-guided techniques, such as computed tomography, fluoroscopy, and ultrasound, are implemented to diagnose and treat the specific site affected by the pain or cancer. This procedure is generally performed with other cancer treatments such as surgery, chemotherapy, and radiation therapy. These procedures offer several advantages: quicker recovery, shorter hospital stays, minimal side effects, and more precise and accurate treatment than other therapeutic procedures.
The rising demand for minimally invasive therapeutics is the key driving factor for the market growth. These procedures could also be used to treat patients with other related comorbidities and in inoperable patients. The capability of minimally invasive techniques to treat cancerous cells better than alternative cancer treatments such as radiation therapy, surgeries, and systematic chemotherapy has helped the technique acquire popularity. Furthermore, healthcare professionals and patients are gradually opting for minimally invasive procedures in the field of interventional oncology due to advantages of using these techniques such as shorter hospital stay, minimal risk of infection, minimal risk of complications, cause less pain, and faster recovery time in comparison to conventional surgeries. These advantages of using minimally invasive procedures will drive market growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of interventional oncology.
The entire interventional oncology market has been sub-categorized into procedure, product, application and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
- Tumor Embolization
- Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy
- Transcatheter Arterial Chemoembolization (TACE)
- Transcatheter Arterial Embolization/Bland Embolization
- Tumor Ablation
- Thermal Ablation
- Microwave Ablation
- Radiofrequency Ablation
- Others (Laser and HIFU)
- Non-Thermal Ablation
- Irreversible Electroporation
- Tumor Embolization
- Radioembolic Agents
- Non-Radioactive Embolic Agents
- Drug-eluting beads
- Tumor Ablation
- Capital Ablation Devices/Generators
- Consumables & Accessories
By End User
- Liver Cancer
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Kidney Cancer
- Bone Metastasis
- Ambulatory Care Centers
- Research & Academia
This section covers regional segmentation which accentuates on current and future demand for interventional oncology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Interventional Oncology Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the interventional oncology market include Boston Scientific Corporation, C. R. Bard, Inc., Medtronic plc, Cook Medical LLC, Merit Medical Systems, Inc., Profound Medical Corp, AngioDynamics, Inc., BTG plc, Terumo Corporation, HealthTronics, Inc., EDAP TMS S.A., Neuwave Medical, Inc., Sirtex Medical Limited, Trod Medical, Teleflex Incorporated, Sanarus Technologies Inc., IMBiotechnologies Ltd., MedWaves, Inc., and IceCure Medical Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.